Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Updates of Healthcare Implementation Communique (SUT) published in Turkey in September 2019

After a long time since the introduction of Healthcare Implementation Communique (SUT) for the first time, the Reimbursement Commission made important changes to the SUT. The main changes relate to higher reimbursement fees for medical devices (5%-100% price increases depending on the category).

Healthcare Implementation Communique (Sağlık Uygulama Tebliği, SUT) is legislation created in 2007 by the Social Security Institute detailing the rules of fees and prices for medical products and services.

Reimbursement fees for procedures and devices were established in 2007 (Healthcare Implementation Communique, SUT) with significant updates in 2013 and only minor adjustments several times a year since then. Minor updates related mainly to pharmaceuticals.

However, in September 2019, the Reimbursement Commission made serious changes to the SUT.

Major updates include the following:

  • Payment rules or reimbursement criteria for medical devices was changed or added;
  • Several codes of medical devices were deleted or added;
  • Reimbursement fees of medical devices increased depending on the category from 5% to 100%;
  • There are no major updates concerning procedures (only change of wording of two procedures and decrease of reimbursement fee for a sweat test procedure).

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.